
Joseph Weiss Jr.
Examiner (ID: 16737)
| Most Active Art Unit | 3761 |
| Art Unit(s) | 3761, 3743, 3735 |
| Total Applications | 359 |
| Issued Applications | 252 |
| Pending Applications | 58 |
| Abandoned Applications | 49 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15086265
[patent_doc_number] => 20190337943
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => SYNTHESIS OF A COMPOUND THAT MODULATES KINASES
[patent_app_type] => utility
[patent_app_number] => 16/510617
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510617 | Synthesis of a compound that modulates kinases | Jul 11, 2019 | Issued |
Array
(
[id] => 17044867
[patent_doc_number] => 11098035
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Compounds, compositions, and methods for increasing CFTR activity
[patent_app_type] => utility
[patent_app_number] => 16/510406
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38545
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16510406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/510406 | Compounds, compositions, and methods for increasing CFTR activity | Jul 11, 2019 | Issued |
Array
(
[id] => 17314391
[patent_doc_number] => 20210403439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => TRIAZOLE GLYCOLATE OXIDASE INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/255600
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27011
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255600
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255600 | Triazole glycolate oxidase inhibitors | Jul 4, 2019 | Issued |
Array
(
[id] => 15023303
[patent_doc_number] => 20190322656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-24
[patent_title] => COMPOUND, AND PRODUCTION METHOD THEREOF, AND METHODS OF TREATMENT USING THE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/502663
[patent_app_country] => US
[patent_app_date] => 2019-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16502663
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/502663 | Compound, and production method thereof, and methods of treatment using the compound | Jul 2, 2019 | Issued |
Array
(
[id] => 15915209
[patent_doc_number] => 10654833
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => ASK1 isoindolin-1-one inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/457101
[patent_app_country] => US
[patent_app_date] => 2019-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 29094
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16457101
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/457101 | ASK1 isoindolin-1-one inhibitors and methods of use thereof | Jun 27, 2019 | Issued |
Array
(
[id] => 15323997
[patent_doc_number] => 20200002328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => PHARMACEUTICAL COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/450261
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22980
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450261 | Pharmaceutical compounds | Jun 23, 2019 | Issued |
Array
(
[id] => 17556010
[patent_doc_number] => 11312686
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Methods and compositions for inhibition of dihydroorotate dehydrogenase
[patent_app_type] => utility
[patent_app_number] => 17/253342
[patent_app_country] => US
[patent_app_date] => 2019-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 51
[patent_no_of_words] => 48725
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17253342
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/253342 | Methods and compositions for inhibition of dihydroorotate dehydrogenase | Jun 21, 2019 | Issued |
Array
(
[id] => 15293325
[patent_doc_number] => 20190389798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => CATALYSTS AND METHODS FOR ENANTIOSELECTIVE CONJUGATE ADDITIONS OF AMINES TO UNSATURATED ELECTROPHILES
[patent_app_type] => utility
[patent_app_number] => 16/448821
[patent_app_country] => US
[patent_app_date] => 2019-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16298
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16448821
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/448821 | Catalysts and methods for enantioselective conjugate additions of amines to unsaturated electrophiles | Jun 20, 2019 | Issued |
Array
(
[id] => 14990813
[patent_doc_number] => 20190314364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE
[patent_app_type] => utility
[patent_app_number] => 16/446397
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16446397
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/446397 | Acetate salt of buprenorphine and methods for preparing buprenorphine | Jun 18, 2019 | Issued |
Array
(
[id] => 14926151
[patent_doc_number] => 20190298713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => ACETATE SALT OF BUPRENORPHINE AND METHODS FOR PREPARING BUPRENORPHINE
[patent_app_type] => utility
[patent_app_number] => 16/446373
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16446373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/446373 | Acetate salt of buprenorphine and methods for preparing buprenorphine | Jun 18, 2019 | Issued |
Array
(
[id] => 16105487
[patent_doc_number] => 10695328
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Aryl dihydropyridinones and piperidinone MGAT2 inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/445913
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47087
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445913
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445913 | Aryl dihydropyridinones and piperidinone MGAT2 inhibitors | Jun 18, 2019 | Issued |
Array
(
[id] => 15797041
[patent_doc_number] => 20200121663
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
[patent_app_type] => utility
[patent_app_number] => 16/430741
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19412
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16430741
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/430741 | B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS | Jun 3, 2019 | Abandoned |
Array
(
[id] => 19564698
[patent_doc_number] => 12139459
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-11-12
[patent_title] => Enhancer of fertilization function of sperm
[patent_app_type] => utility
[patent_app_number] => 15/734579
[patent_app_country] => US
[patent_app_date] => 2019-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32255
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 448
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734579
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734579 | Enhancer of fertilization function of sperm | Jun 3, 2019 | Issued |
Array
(
[id] => 16353078
[patent_doc_number] => 10793579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => Bicyclic-fused heteroaryl or aryl compounds
[patent_app_type] => utility
[patent_app_number] => 16/411679
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 86975
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411679 | Bicyclic-fused heteroaryl or aryl compounds | May 13, 2019 | Issued |
Array
(
[id] => 15649515
[patent_doc_number] => 20200087287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-19
[patent_title] => CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/411598
[patent_app_country] => US
[patent_app_date] => 2019-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16411598
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/411598 | CRYSTALLINE PHARMACEUTICAL AND METHODS OF PREPARATION AND USE THEREOF | May 13, 2019 | Abandoned |
Array
(
[id] => 16726470
[patent_doc_number] => 20210093617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-01
[patent_title] => Method of Treating Cancer With Atpenin A5 Derviatives
[patent_app_type] => utility
[patent_app_number] => 17/054235
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054235 | Method of Treating Cancer With Atpenin A5 Derviatives | May 8, 2019 | Abandoned |
Array
(
[id] => 16042861
[patent_doc_number] => 10683289
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-16
[patent_title] => Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/400498
[patent_app_country] => US
[patent_app_date] => 2019-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20133
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 394
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400498
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400498 | Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof | Apr 30, 2019 | Issued |
Array
(
[id] => 16353073
[patent_doc_number] => 10793574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-06
[patent_title] => TYK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/399296
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 76016
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16399296
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/399296 | TYK2 inhibitors and uses thereof | Apr 29, 2019 | Issued |
Array
(
[id] => 16711801
[patent_doc_number] => 20210078948
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PHENYL AMINO SODIUM PROPIONATE DERIVATIVE, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/053364
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3960
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053364 | Phenyl amino sodium propionate derivative, preparation method therefor and application thereof | Apr 28, 2019 | Issued |
Array
(
[id] => 16900686
[patent_doc_number] => 20210179602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => A 5-THIAZOLECARBOXAMIDE KINASE INHIBITOR AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/048772
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56816
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -47
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048772
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048772 | 5-thiazolecarboxamide kinase inhibitor and uses thereof | Apr 22, 2019 | Issued |